The federal contract award is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,561.83 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 1, 2024, with a completion date of November 4, 2024. The contract is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Generated 1/31/25, 9:20 AM